Geneva, Oct. 9 -- International Clinical Trials Registry received information related to the study (ChiCTR2600133317) titled 'Construction and Validation of a Deep Learning-Based Pathological Diagnostic Scoring System for Acral Melanocytic Tumors and Evaluation of Its Clinical Assistance Performance' on Sept. 24.

Study Type: Observational study

Study Design: Sequential

Primary Sponsor: Chinese PLA General Hospital

Condition: Acral melanocytic tumors

Recruitment Status: Not Recruiting

Phase: N/A

Date of First Enrollment: 2026-09-24

Target Sample Size: Observation Group of Cutaneous Melanoma Cells Tumors:450;

Countries of Recruitment: China

To know more, visit https://www.chictr.org.cn/showproj.html?proj=332673

Published by...